S
Selkirk Pharma
Fill/finish cmo located in the healthcare hub of the pacific northwest
About Selkirk Pharma
Selkirk Pharma is a cutting-edge contract manufacturing organization (CMO) that specializes in Fill/Finish services, a crucial step in the pharmaceutical manufacturing process where the drug product is filled into its final container. Located in the healthcare hub of the Pacific Northwest, Selkirk Pharma serves pharmaceutical companies, acting as a crucial partner in the production of their products.
The company operates in the healthcare and pharmaceutical industry, specifically in the drug manufacturing sector. It uses the latest filling technology, automatic data acquisition, and digital quality management systems to ensure the reliable supply of its clients' products. This high-tech approach helps to maintain the quality and safety of the drugs, which is critical to the health of patients.
Selkirk Pharma's business model is based on contract manufacturing, meaning they produce drugs on behalf of other companies. This is a common practice in the pharmaceutical industry, allowing companies to focus on research and development while outsourcing the manufacturing process. Selkirk Pharma generates revenue by charging fees for their manufacturing services.
The company prides itself on its partnership philosophy, treating its clients' products and patients as their own. This is reflected in their purpose-built manufacturing facility which ensures a unidirectional flow throughout the production process, enhancing efficiency and quality control. The team at Selkirk Pharma is comprised of experienced professionals, with an average of over 20 years in the industry, further strengthening their capability to deliver high-quality services.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2018
- Headquarters
- Spokane, United States
- Employees
- 11
- Open positions
- None listed
- Dealroom signal
- 26.4/100
- Industry
- Health
- Sub-industry
- Pharmaceutical, BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SEEDOther financing | Aug 2023 | $24M | $375M | Undisclosed | ↗ |
| EARLY VCOther financing | Dec 2021 | $35M | $140M | Undisclosed | — |
Growth signals
Latest recorded traffic for Selkirk Pharma is 940 monthly website visits, down 50.5% over the last three months. Selkirk Pharma's team declined 21.4% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Selkirk Pharma on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Selkirk Pharma’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







